Interestingly, increased IL-17 production by MAIT cells is very likely not just a sign of augmented activation, but rather represents a more pronounced differentiation toward a type-17 phenotype in MS patients, linked to IL-7 signaling (45). Here, IL7 is linked to myeloid sarcoma.